Literature DB >> 20471687

Evaluation of axial length measurement of the eye using partial coherence interferometry and ultrasound in cases of macular disease.

Takashi Kojima1, Akeno Tamaoki, Norihiko Yoshida, Tatsushi Kaga, Chikako Suto, Kazuo Ichikawa.   

Abstract

PURPOSE: The present study evaluated the accuracy of using partial coherence interferometry (PCI) and ultrasound (US) to measure axial length in eyes with macular disease, the nature of the double peak (DP) in PCI measurements, and the applicability of intraocular lens (IOL) power calculation.
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: We studied 132 eyes with macular edema, epiretinal membrane, and macular hole in 132 patients who underwent combined cataract and vitrectomy surgery.
METHODS: Axial length was measured using PCI and US. If a DP was observed in the PCI measurement, the posterior peak was used for the IOL calculation. The central retinal thickness (CRT) was measured using optical coherence tomography. MAIN OUTCOME MEASURES: Measurements were made of the frequency of DP observation in PCI measurement and the postoperative refractive errors when either PCI or US measurements were applied.
RESULTS: A DP was observed in 25 (18.7%) of 132 eyes in the axial length measurement using PCI. There was a significant correlation between the interpeak distance and the CRT (P<0.001, r(2)=0.3869). The 6-month postoperative refractive errors in the DP and single peak (SP) groups were predicted correctly within +/-0.5 diopters in 56.0% (DP) and 61.7% (SP) of the cases and within +/-1.0 diopters in 92.0% (DP) and 92.2% (SP) of the cases. The accuracy of the axial length measurement was similar between PCI and US.
CONCLUSIONS: Our results suggest that the longer axial length of the DP observed in PCI represents retinal pigment epithelium. If a DP was observed in PCI measurement, application of the longer peak for the IOL calculation resulted in a refractive error similar to that in the SP group.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20471687     DOI: 10.1016/j.ophtha.2010.01.018

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Postoperative refractive error after phacovitrectomy for epiretinal membrane with and without macular oedema.

Authors:  Andreas Frings; Simon Dulz; Christos Skevas; Birthe Stemplewitz; Stephan J Linke; Gisbert Richard; Lars Wagenfeld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-06       Impact factor: 3.117

2.  Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length.

Authors:  Andrea Cacciamani; Francesco Oddone; Mariacristina Parravano; Fabio Scarinci; Marta Di Nicola; Giorgio Lofoco
Journal:  Jpn J Ophthalmol       Date:  2012-10-24       Impact factor: 2.447

3.  Intraocular lens power estimation in combined phacoemulsification and pars plana vitrectomy in eyes with epiretinal membranes: a case-control study.

Authors:  Min Kim; Hyoung Eun Kim; Dong Hyun Lee; Hyoung Jun Koh; Sung Chul Lee; Sung Soo Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

4.  Postoperative Refractive Prediction Error Measured by Optical and Acoustic Biometry after Phacovitrectomy for Rhegmatogenous Retinal Detachment without Macular Involvement.

Authors:  Masashi Sakamoto; Izumi Yoshida; Takahiro Sodeno; Asao Sakai; Hidetaka Masahara; Takatoshi Maeno
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

5.  Axial length estimation error caused by hidden double-peak on partial coherence interferometry in an eye with epiretinal membrane: a case report.

Authors:  Yoshiyuki Kitaguchi; Shinsaku Yano; Fumi Gomi
Journal:  Clin Ophthalmol       Date:  2014-03-13

6.  Long-Term Reproducibility of Axial Length after Combined Phacovitrectomy in Macula-sparing Rhegmatogenous Retinal Detachment.

Authors:  Tae-Seen Kang; Hye-Jin Park; Young-Joon Jo; Jung-Yeul Kim
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.